[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100569948":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":12,"centralContacts":17,"locations":25,"responsibleParty":38,"collaborators":42,"id":46,"slug":47,"hasResults":48,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":10,"eligibilityCriteria":52,"healthyVolunteers":48,"sex":53,"minAge":54,"maxAge":10,"enrollmentInfo":55,"targetDuration":10,"studyType":58,"phases":10,"briefSummary":59,"conditions":60,"keywords":63,"overallStatus":27,"whyStopped":10,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Mahidol University","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":10},"160 End-stage renal disease patients",null,"End-stage renal disease on renal replacement therapy (hemodialysis or peritoneal dialysis) or status-post-living donor or deceased donor kidney transplantation aged more than or equal 18 years",[13],{"name":14,"affiliation":15,"role":16},"Punnee Pitisuttithum, Prof. E.","Vaccine Trial Centre, Faculty of Tropical Medicine, Mahidol University","STUDY_CHAIR",[18,23],{"name":19,"role":20,"phone":21,"phoneExt":10,"email":22},"Tanaya Siripoon, M.D.","CONTACT","6626435599","Tanaya.sir@mahidol.edu",{"name":14,"role":20,"phone":21,"phoneExt":10,"email":24},"punnee.pit@mahidol.ac.th",[26],{"facility":15,"status":27,"city":28,"state":10,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":10},"RECRUITING","Bangkok","10400","Thailand","TH",{"type":33,"coordinates":34},"Point",[35,36],100.50144,13.75398,{"lat":36,"lon":35},{"type":39,"investigatorFullName":40,"investigatorTitle":41,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"PRINCIPAL_INVESTIGATOR","Punnee Pitisuttithum","Professor",[43],{"name":44,"class":45},"National Research Council of Thailand","OTHER_GOV","100569948","evaluation-of-igra-symptoms-and-chest-radiograph-for-subclinical-tb-detection-in-esrd-and-kt-100569948",false,"NCT06700876","Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT","Evaluation of Interferon-gamma Release Assays, Symptom Screening and Chest Radiograph for Detection of Subclinical Tuberculosis of End-stage Kidney Disease and Kidney Transplant Recipients in Thailand","Inclusion Criteria:\n\n1. End-stage renal disease on renal replacement therapy (hemodialysis or peritoneal dialysis) or status-post-living donor or deceased donor kidney transplantation\n2. Aged more than or equal 18 years\n\nExclusion Criteria:\n\n1. Positive PPD test or a previously documented positive PPD\n2. Active pulmonary or extrapulmonary tuberculosis","ALL","18 Years",{"count":56,"type":57},160,"ESTIMATED","OBSERVATIONAL","This is an observational study among approximately 160 end-stage renal disease patients on renal replacement therapy and post-living donor or deceased donor kidney transplant recipients. Investigators aim to assess the proportion of positive IGRA associated with symptom development, sputum Xpert MTB\u002FRIF assay, and chest radiograph to define latent TB infection and subclinical TB among ESKD and renal transplant patients.",[61,62],"Tuberculosis (TB)","End-Stage Kidney Disease",[64,65,66,67,68,69],"Subclinical Tuberculosis","Interferon gamma release assays","End-stage Kidney Disease","Detection of Subclinical Tuberculosis","Tuberculosis","IGRAs","2024-11-20",{"date":72,"type":73},"2024-11-22","ACTUAL",{"date":75,"type":73},"2024-08-06",{"date":77,"type":57},"2027-06-30",{"name":5,"class":6},1]